Abstract
A series of 1,2,4-triazole-schiff hybrids were synthesized and characterized by mass spectrometry, FTIR and NMR spectroscopy. The compounds were screened for anticancer activity against human breast cancer cell line (MCF-7 and T47D) and human cervical cancer cell line (HeLa). The result indicates that newly synthesized compounds exhibit cytotoxicity to all cell lines studied. In particular, MCF-7 cells were shown to be more sensitive with EC50 < 50 μM/ml with the exception of compound T2. Interestingly, T6 produced more high cytotoxicity on MCF-7 cells (< 10 μM/ml), which is comparable to cisplatin EC50 13.10 μM/ml. To further investigate the mode of cell death, early and late apoptosis studies were done on MCF-7 cells. The externalization of phosphatidylserine and DNA fragmentation supports the apoptosis as the major mode of cell death induced by derivatives on MCF-7 cells.
Graphic abstract
References
B. Khademi, A. Moradi, S. Hoseini, M. Mohammadianpanah, Oral Maxillofac. Surg. 13, 191 (2009)
R.K. Jain, Cancer Res. 48, 2641 (1988)
L.M. Coussens, Z. Werb, Nature 420, 860 (2002)
T. Reya, S.J. Morrison, M.F. Clarke, I.L. Weissman, Nature 414, 105 (2001)
I.J. Fidler, Nat. Rev. Cancer 3, 453 (2003)
A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, CA Cancer J. Clin. 61, 69 (2011)
D. Saranath, A. Khanna, Biomed. Res. J. 1, 1 (2014)
P. Kleihues, L.H. Sobin, Cancer 88, 2887 (2000)
W. H. Organization and W. H. O. M. S. A. Unit, Global Status Report on Alcohol and Health, 2014 (World Health Organization, 2014)
S. Nik-Zainal, P. Van Loo, D.C. Wedge, L.B. Alexandrov, C.D. Greenman, K.W. Lau, K. Raine, D. Jones, J. Marshall, M. Ramakrishna, Cell 149, 994 (2012)
J. Maddams, D. Brewster, A. Gavin, J. Steward, J. Elliott, M. Utley, H. Møller, Br. J. Cancer 101, 541 (2009)
D.O. Ochwang’i, C.N. Kimwele, J.A. Oduma, P.K. Gathumbi, J.M. Mbaria, S.G. Kiama, J. Ethnopharmacol. 151, 1040 (2014)
K.S. Courneya, C.M. Friedenreich, Ann. Behav. Med. 21, 171 (1999)
C. Yu, S. Fan, Y. Sun, E. Pickwell-MacPherson, Quant. Imaging Med. Surg. 2, 33 (2012)
A. van’t Spijker, R.W. Trijsburg, H.J. Duivenvoorden, Psychosom. Med. 59, 280 (1997)
M. Faisal, M. Ahmed, S. Hussain, F.A. Larik, A. Saeed, Green Process. Synth. 8, 635 (2019)
M. Faisal, Z.U. Rehman, Q. ul Aein, A. Saeed, Mater. Chem. Phys. 231, 272–280 (2019)
K.J.M. Schimmel, D.J. Richel, R.B.A. van den Brink, H.-J. Guchelaar, Cancer Treat. Rev. 30, 181 (2004)
N.R. Bachur, S.L. Gordon, M.V. Gee, Cancer Res. 38, 1745 (1978)
J.W. Larrick, S.C. Wright, FASEB J. 4, 3215 (1990)
T. Ariga, T. Seki, BioFactors 26, 93 (2006)
C. Isanbor, D. O’Hagan, J. Fluor. Chem. 127, 303 (2006)
R. Kaur, A. Ranjan Dwivedi, B. Kumar, V. Kumar, Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem. Agents) 16, 465 (2016)
K.K. Mann, B. Wallner, I.S. Lossos, W.H. Miller Jr., Expert Opin. Investig. Drugs 18, 1727 (2009)
M. Faisal, A. Haider, Q. ul Aein, A. Saeed, F.A. Larik, Front. Chem. Sci. Eng. 13, 586 (2019)
M. Faisal, F.A. Larik, A. Saeed, J. Porous Mater. 26, 455 (2019)
T.M. Allen, P.R. Cullis, Science (80-) 303, 1818 (2004)
J.F. Fries, P.W. Spitz, C.A. Williams, D.A. Bloch, G. Singh, H.B. Hubert, Arthritis Rheum. Off. J. Am. Coll. Rheumatol. 33, 121 (1990)
A.-M. Florea, D. Büsselberg, Cancers (Basel) 3, 1351 (2011)
M. Hogan, J. Claffey, C. Pampillón, R.W.G. Watson, M. Tacke, Organometallics 26, 2501 (2007)
K. Spiegel, A. Magistrato, P. Carloni, J. Reedijk, M.L. Klein, J. Phys. Chem. B 111, 11873 (2007)
P. Nagender, R.N. Kumar, G.M. Reddy, D.K. Swaroop, Y. Poornachandra, C.G. Kumar, B. Narsaiah, Bioorg. Med. Chem. Lett. 26, 4427 (2016)
M.A. Islam, Y. Zhang, Y. Wang, S.R. McAlpine, Medchemcomm 6, 300 (2015)
D. Kumar, N.M. Kumar, K.-H. Chang, K. Shah, Eur. J. Med. Chem. 45, 4664 (2010)
S.I. El-Naem, A.O. El-Nzhawy, H.I. El-Diwani, A.O. Abdel Hamid, Arch. Pharm. Int. J. Pharm. Med. Chem. 336, 7 (2003)
K. Karrouchi, L. Chemlal, J. Taoufik, Y. Cherrah, S. Radi, M.E.A. Faouzi, M. Ansar, Ann. Pharm. Fr. (Elsevier, Amsterdam, 2016), pp. 431–438
J.K. Shneine, Y.H. Alaraji, Spectroscopy 9, 9c (2016)
M.-A. Hahn, R.H. Adamson, J. Natl. Cancer Inst. 48, 783 (1972)
Y. Ding, Z. Zhang, G. Zhang, S. Mo, Q. Li, Z. Zhao, Res. Chem. Intermed. 42, 3105 (2016)
M. Belkadi, A.A. Othman, Trends Appl. Sci. Res. 6, 19 (2011)
M. Faisal, S. Hussain, A. Haider, A. Saeed, F.A. Larik, Chem. Pap. 73, 1053 (2019)
M. Faisal, A. Saeed, F.A. Larik, S.A. Ghumro, S. Rasheed, P.A. Channar, J. Electron. Mater. 47, 7011 (2018)
R.Y. Ambaye, M.A. Indap, S.D. Naik, J. Cancer Res. Clin. Oncol. 115, 379 (1989)
T. Ravishankar, K. Chinnakali, N. Arumugam, P.C. Srinivasan, A. Usman, H.-K. Fun, Acta Crystallogr. Sect. E Struct. Rep. Online 59, o1903 (2003)
S.D. Naik, R.Y. Ambaye, S.V. Gokhale, Anticancer Res. 7, 87 (1987)
T. Matviiuk, F. Rodriguez, N. Saffon, S. Mallet-Ladeira, M. Gorichko, A.L.D.J.L. Ribeiro, M.R. Pasca, C. Lherbet, Z. Voitenko, M. Baltas, Eur. J. Med. Chem. 70, 37 (2013)
P.A. Channar, A. Saeed, F.A. Larik, S. Rashid, Q. Iqbal, M. Rozi, S. Younis, J. Mahar, Biomed. Pharmacother. 94, 499 (2017)
A. Saeed, A. Mumtaz, J. Saudi Chem. Soc. 21, 186 (2017)
A. Saeed, M. Batool, Med. Chem. Res. 16, 143 (2007)
V.M. Chernyshev, A.V. Chernysheva, Z.A. Starikova, Heterocycles 81, 2291 (2010)
T. Mosmann, J. Immunol. Methods 65, 55 (1983)
M. Islamiah, N. Ismail, H. Mohamad, Y.Y. Sung, T.S.T. Muhammad, Int. J. Res. Pharm. Sci. 9, 328 (2018)
M. Faisal, F.A. Larik, M. Salman, A. Saeed, Kinet. Catal. 60, 522 (2019)
R.F.A. Zwaal, P. Comfurius, E.M. Bevers, Cell. Mol. Life Sci. C. 62, 971 (2005)
Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson, J. Cell Biol. 119, 493 (1992)
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mahar, J., Saeed, A., Chaudhry, GeS. et al. Synthesis, characterization and cytotoxic studies of novel 1,2,4-triazole-azomethine conjugates. J IRAN CHEM SOC 17, 943–951 (2020). https://doi.org/10.1007/s13738-019-01826-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-019-01826-9